omeprazole has been researched along with Drug-Induced Stevens Johnson Syndrome in 11 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After 2 months of treatment with imatinib 400 mg/day, a 60-year-old white female affected by GIST developed bilateral palpebral edema with hyperemic conjunctivae and labial edema when lansoprazole 15 mg/day was introduced to treat dyspeptic symptomatology." | 7.73 | Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. ( Ardau, R; Chillotti, C; De Lisa, R; Del Zompo, M; Severino, G, 2005) |
| "Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) have been associated with some drugs, particularly anticonvulsants such as phenytoin." | 3.74 | [Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy]. ( Fernández, FA; Garcés, FJ; Pintor, E; Quesada, R, 2007) |
| "After 2 months of treatment with imatinib 400 mg/day, a 60-year-old white female affected by GIST developed bilateral palpebral edema with hyperemic conjunctivae and labial edema when lansoprazole 15 mg/day was introduced to treat dyspeptic symptomatology." | 3.73 | Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. ( Ardau, R; Chillotti, C; De Lisa, R; Del Zompo, M; Severino, G, 2005) |
| "A diagnosis of toxic epidermal necrolysis (TEN) was made." | 2.45 | Toxic epidermal necrolysis and neutropaenia: complications of omeprazole. ( Burke, A; Burns, A; Handfield-Jones, S; Palmer, M; Sinha, A; Thakor, AS, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Van Tendeloo, E | 1 |
| Gutermuth, J | 1 |
| Grosber, M | 1 |
| Ladizinski, B | 1 |
| Sankey, C | 1 |
| Roman, J | 1 |
| Nguyen, KD | 1 |
| Dominguez, AR | 1 |
| Thakor, AS | 1 |
| Burke, A | 1 |
| Handfield-Jones, S | 1 |
| Sinha, A | 1 |
| Palmer, M | 1 |
| Burns, A | 1 |
| Chularojanamontri, L | 1 |
| Jiamton, S | 1 |
| Manapajon, A | 1 |
| Suvanasuthi, S | 1 |
| Kulthanan, K | 1 |
| Dhana, N | 1 |
| Jongjarearnprasert, K | 1 |
| Severino, G | 1 |
| Chillotti, C | 1 |
| De Lisa, R | 1 |
| Del Zompo, M | 1 |
| Ardau, R | 1 |
| Heaton, NR | 1 |
| Edmonds, EV | 1 |
| Francis, ND | 1 |
| Bunker, CB | 1 |
| Bowling, JC | 1 |
| Morar, N | 1 |
| Revuz, J | 1 |
| Fernández, FA | 1 |
| Pintor, E | 1 |
| Quesada, R | 1 |
| Garcés, FJ | 1 |
| Cox, NH | 1 |
1 review available for omeprazole and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Toxic epidermal necrolysis and neutropaenia: complications of omeprazole.
Topics: Acute Kidney Injury; Adult; Biopsy, Needle; Combined Modality Therapy; Diabetes Mellitus, Type 1; Di | 2009 |
10 other studies available for omeprazole and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Positive patch testing with omeprazole in Stevens-Johnson syndrome: a case report.
Topics: Humans; Omeprazole; Patch Tests; Stevens-Johnson Syndrome | 2021 |
A topical matter: toxic epidermal necrolysis.
Topics: Acetaminophen; Analgesics, Opioid; Anti-Inflammatory Agents; Anticonvulsants; Antiemetics; Antineopl | 2014 |
A diffuse desquamative rash in an elderly male.
Topics: Aged; Calcium Channel Blockers; Diagnosis, Differential; Diltiazem; Humans; Lupus Erythematosus, Cut | 2017 |
Cutaneous reactions to proton pump inhibitors: a case-control study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Cas | 2012 |
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antineoplastic Agents; Benzamides; Drug Eruptions; Edema; F | 2005 |
Fatal toxic epidermal necrolysis due to lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Drug Eruptions; Erythema Multiform | 2004 |
Fatal toxic epidermal necrolysis due to lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Diagnosis, Differential; Drug Eruptions; | 2006 |
[Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy].
Topics: Adenocarcinoma; Aged; Anticonvulsants; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; | 2007 |
Pantoprazole (Protonix).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Clinical Trials as Topic; Dose-Response Rel | 2000 |
Acute disseminated epidermal necrosis due to omeprazole.
Topics: Acute Disease; Aged; Diagnosis, Differential; Erythema Multiforme; Female; Humans; Omeprazole; Pemph | 1992 |